Table 6.

Unmet needs in cardio-oncology

Well-structured, validated protocols for patient assessment and monitoring Clinical trials specifically designed to assess the prevention and management of adverse CV effects of cancer therapy including the timing and choice of intervention Clinical trials evaluating the use of CV drugs in patients receiving newer cancer treatments Harmonized and standardized definitions of cardiac endpoints in oncology trials Greater patient and physician education on the long-term risks, and need for follow-up Increased availability of cardio-oncology clinics Clinical trials of shared care models, and specially designed programmes, to successfully transition cancer survivors from oncology or cardio-oncology centres to primary care physicians

CV, cardiovascular.